JAMA • 2020.02.11
Tong S.Y.C., Lye D.C., Yahav D., Sud A., Robinson J.O., Nelson J., Archuleta S., Roberts M.A., Cass A., Paterson D.L., Foo H., Paul M., Guy S.D:, Tramontana A.R., Walls G.B., McBride S., Bak S., Ghosh N., Rogers B.A., Ralph A.P., Davies J., Ferguson P.E., Dotel r., McKew G.L., Gray T.L., Holmes N.E., Smith S., Warner M.S., Kalimuddin S., Young B.E., Runnegar N., Andresen D.N., Anagnostou N.A., Johnson S.A., Chatfield M.D., Cheng A.C., Fowler V.G. Jr, Howden B.P., Meagher N., Price D.J., van Hal S.J., O'Sullivan M.V.N., Davis J.S., Australasian Society for Infectious Diseases Clinical Research Network
- Clinical trial
- International
- Bacteremia, beta-lactams, Cefazolin, Clinical trial, Cloxacillin, Daptomycin, Floxacillin, MRSA, Vancomycin